Longitudinal predictor analysis of pain in breast cancer survivors on aromatase inhibitors—the PAC-WOMAN trial
Authors:
Open Access
- 14 May 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pain Research
- Vol. 7, 1700365
Abstract
Objective: Breast cancer survivors undergoing hormonal therapy with aromatase inhibitors face a significantly increased risk of developing musculoskeletal pain, leading to treatment discontinuation rates of 13% to 22%. Recent literature has focused on identifying and understanding possible risk factors for pain development in breast cancer survivors, not only for pain prevention but also for guiding treatment strategies. This study aimed to investigate predictors of baseline, 4-month, and change scores of pain intensity in breast cancer survivors on aromatase inhibitors. Methods: Multiple regression analyses using intent-to-treat data ( N = 110; mean age 56.2 ± 7.7 years) were performed to identify possible predictors applying a biopsychosocial approach with five domains: sociodemographic characteristics, treatment-related factors, health-related factors, physical function factors, and group allocation. The Brief Pain Inventory was used to assess participants' pain intensity. Results: Having a partner (95% CI: 0.220, 1.868, p = 0.014), lower sleep quality (95% CI: −1.694, −0.615, p < 0.000), and additional time on the Timed-up-and-go test (95% CI: 0.002, 1.185, p = 0.049) were significant predictors of higher baseline pain intensity. Significant predictors of higher 4-month pain included lower sleep quality (95% CI: −1.095, −0.054, p = 0.031), lower chest press strength (95% CI: −0.231, −0.032, p = 0.010) and being in the brief physical activity counseling group (95% CI: 0.324, 2.155, p = 0.008) relative to the exercise group. In the change scores model, compared to the exercise group, being in the brief physical activity counseling group (95% CI: 0.183, 1.068, p = 0.006), and waitlist control group (95% CI: 0.054, 0.947, p = 0.029) significantly predicted an increase in pain intensity over time. Conversely, having a partner (95% CI: −0.825, −0.057, p = 0.025) significantly predicted a reduction in pain intensity. Conclusions: These findings highlight the complex and multifaceted nature of pain in this population and the need for longitudinal studies with diverse populations, as well as advanced methodologies to capture the dynamic nature of pain and refine intervention strategies.Keywords
This publication has 46 references indexed in Scilit:
- Chronic pain and its correlates among long-term breast cancer survivorsJournal of Cancer Survivorship, 2022
- The Importance of Sleep for People With Chronic Pain: Current Insights and EvidenceJBMR Plus, 2022
- Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanismsMolecular Oncology, 2020
- Breast cancer and chronic pain: a mixed methods reviewIrish Journal of Medical Science (1971 -), 2018
- Risk factors of pain in breast cancer survivors: a systematic review and meta-analysisSupportive Care in Cancer, 2017
- Clinically Relevant Physical Benefits of Exercise Interventions in Breast Cancer SurvivorsCurrent Oncology Reports, 2016
- Socio-demographic, treatment-related, and health behavioral predictors of persistent pain 15 months and 7–9 years after surgery: a nationwide prospective study of women treated for primary breast cancerBreast Cancer Research and Treatment, 2015
- Pain in long-term breast cancer survivors: the role of body mass index, physical activity, and sedentary behaviorBreast Cancer Research and Treatment, 2012
- Long-term course of pain in breast cancer survivors: a 4-year longitudinal studyBreast Cancer Research and Treatment, 2011
- Physical activity, long-term symptoms, and physical health-related quality of life among breast cancer survivors: A prospective analysisJournal of Cancer Survivorship, 2007